J. Fruchart

发表

PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.

R. Bordet, D. Deplanque, B. Staels, 2006, Biochemical Society transactions.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

S. Grundy, J. Cleeman, K. Donato, 2009, Circulation.

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

F. Sacks, P. Zimmet, C. Wanner, 2008, Diabetes & vascular disease research.

Enhanced VDUP‐1 gene expression by PPARγ agonist induces apoptosis in human macrophage

K. Brand, L. Billiet, J. Fruchart, 2008 .

Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake.

M. Romon, N. Marécaux, P. Lebel, 1999, American journal of physiology. Endocrinology and metabolism.

Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications

B. Staels, J. Fruchart, G. Chinetti, 2003, International Journal of Obesity.

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

J. Auwerx, J. Dallongeville, K. Schoonjans, 1995, The Journal of clinical investigation.

Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia

G. Luc, J. Fruchart, P. Drouin, 2004, European Journal of Clinical Pharmacology.

Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake.

J. Fruchart, O. Briand, V. Clavey, 2000, Arteriosclerosis, thrombosis, and vascular biology.

HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age.

A. Hamsten, F. Karpe, J. Fruchart, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids.

J. Auwerx, P. Calder, P. Denéfle, 1995, European Journal of Biochemistry.

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.

F. H. Man, A. Van der Laarse, L. Havekes, 2000, Atherosclerosis.

PPARS, metabolic disease and atherosclerosis.

B. Staels, J. Fruchart, P. Duriez, 2001, Pharmacological research.

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.

F. Gonzalez, Y. Inoue, B. Staels, 2003, Gastroenterology.

Familial hypoalphalipoproteinemia in premature coronary artery disease.

J. Ordovás, J. Fruchart, E. J. Schaefer, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E.

J. Fruchart, V. Clavey, J. Bard, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall

B. Staels, J. Fruchart, G. Chinetti, 2001, Zeitschrift für Kardiologie.

Anion-exchange fast protein liquid chromatographic characterization and purification of apolipoproteins A-I, A-II, C-I, C-II, C-III0, C-III1, C-III2 and E from human plasma.

V. Clavey, A. Barkia, H. Mezdour, 1987, Journal of chromatography.

Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris.

G. Luc, G. Franceschini, C. Sirtori, 2000, Atherosclerosis.

Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study.

D. Arveiler, J. Ferrières, L. Elkhalil, 2003, Atherosclerosis.

Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia.

V. Gudnason, S. Humphries, J. Fruchart, 1993, Journal of medical genetics.

Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes.

P. Wilson, G. Luc, J. Ordovás, 1996, Journal of lipid research.

Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle

J. Auwerx, C. L. Fur, J. Dallongeville, 1998, International Journal of Obesity.

Effects of dietary maritime pine seed oil on lipoprotein metabolism and atherosclerosis development in mice expressing human apolipoprotein B

J. Dallongeville, J. Fruchart, R. Wolff, 2001, European journal of nutrition.

Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosa.

J. Fruchart, C. Feillet-Coudray, J. Bard, 2000, Clinica chimica acta; international journal of clinical chemistry.

Pinus pinaster oil affects lipoprotein metabolism in apolipoprotein E-deficient mice.

J. Dallongeville, J. Fruchart, R. Wolff, 1999, The Journal of nutrition.

Influence of mental stress and circadian cycle on postprandial lipemia.

J. Dallongeville, P. Devos, M. Romon, 1999, The American journal of clinical nutrition.

In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.

D. Rader, H. Brewer, J. Fruchart, 1991, Journal of lipid research.

Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.

J. Ordovás, P. Wilson, E. Schaefer, 1991, Atherosclerosis.

Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.

J. Fruchart, J. Bard, J. Auget, 1990, Atherosclerosis.

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women

S. Tonstad, J. Fruchart, J. Bard, 1995, Journal of internal medicine.

Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.

J. Fruchart, T. Crea, B. Guerci, 1996, Metabolism: clinical and experimental.

Genetic Determinants of Responsiveness to the HMG‐CoA Reductase Inhibitor Fluvastatin in Patients With Molecularly Defined Heterozygous Familial Hypercholesterolemia

Y. Friedlander, V. Meiner, S. Eisenberg, 1993, Circulation.

Transcriptional control of adipogenesis.

J. Auwerx, L. Fajas, J. Fruchart, 1998, Current opinion in cell biology.

Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage.

K. Brand, L. Billiet, J. Fruchart, 2008, Journal of cellular physiology.

High-density lipoprotein subclasses and apolipoprotein A-I.

J. Fruchart, P. Duriez, J. Fruchart, 1999, Clinica chimica acta; international journal of clinical chemistry.

Influence of serum amyloid A on cholesterol esterification in human plasma.

G. Hocke, J. Fruchart, R. Saïle, 1989, Biochimica et biophysica acta.

Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.

J. Dallongeville, P. Nilsson-ehle, H. Thysell, 1995, Kidney international.

P. Amouyel, D. Cottel, J. Dallongeville, 2000, Atherosclerosis.

Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.

A. V. Sechkin, B. Staels, J. Fruchart, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels.

P. Amouyel, J. Dallongeville, M. Fantino, 1997, Metabolism: clinical and experimental.

Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

E. Hachulla, J. Fruchart, P. Hatron, 2000, Lupus.

Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells.

D. Hum, B. Staels, J. Fruchart, 1999, European journal of biochemistry.

Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresis.

P. Amouyel, J. Fruchart, P. Duriez, 1990, Clinica chimica acta; international journal of clinical chemistry.